mechanisms of anti-angiogenic therapy in lung cancer
Published 7 years ago • 733 plays • Length 5:29Download video MP4
Download video MP3
Similar videos
-
3:00
nsclc: mechanisms of resistance to antiangiogenic therapy
-
6:11
how does antiangiogenic therapy work?
-
5:29
resistance to antiangiogenic therapy in lung cancer
-
3:05
rationale behind antiangiogenic therapy in nsclc
-
9:12
the current role for antiangiogenic therapy for nsclc
-
6:01
future directions for antiangiogenic therapy in lung cancer
-
5:43
antiangiogenic therapy in advanced nsclc
-
18:58
mechanisms of angiogenesis inhibitors in metastatic colorectal cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
3:55
sequencing and combining therapies with antiangiogenic monoclonal antibodies
-
4:08
dysregulated angiogenesis in lung cancer
-
3:07
targeting angiogenesis in non–small cell lung cancer
-
3:02
using antiangiogenic therapy in stage 4 nsclc
-
2:56
rationale for anti-angiogenesis in lung cancer
-
4:15
current concepts in anti-angiogenic therapy for non-small cell lung cancer
-
4:17
blocking vegfr2 vs vegfa or vegfb in lung cancer
-
1:07
dr. garon on differences between antiangiogenic agents in lung cancer
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
3:56
antiangiogenic antibodies vs tkis in nsclc